Keywords: Hyperpolarized MR (Non-Gas), Metabolism, Cancer, Hepatocellular carcinoma
Motivation: To offer patients curative treatment for hepatocellular carcinoma (HCC) it is crucial to make the diagnosis as early as possible. The sensitivity for diagnosis of HCC smaller than 1 cm with traditionally MRI is low.
Goal(s): We aim to investigate if adding hyperpolarized [1-13C] pyruvate to the conventional MRI exam can improve the diagnosis and aggressiveness assessment of HCC by characterizing tumor metabolism.
Approach: We used hyperpolarized [1-13C] pyruvate MRI to assess tumor metabolism in patients with HCC.
Results: Results show altered metabolism in confirmed HCC and interestingly a case of glutaminase synthase positive HCC shows increased alanine/pyruvate compared to non-tumor liver.
Impact: Hyperpolarized MRI in patients with HCC is feasible and may be used to detect early HCC and might characterize glutaminase synthase positive tumors non-invasively by increased alanine production.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords